-
Diagnostics World News | Crosscope and Farcast Bioscience created OrionAI–an artificially intelligent (AI) diagnostic assistant for tumor histological examination. Crosscope developed the AI-enabled digital pathology platform and proprietary algorithms, while Farscape Bioscience created the histoculture platform that preserves entire human tumor microenvironments. OrionAI increases diagnostic speed and lowers misdiagnosis rates of head and neck squamous cell carcinoma, a highly prevalent disease worldwide.
May 31, 2022
-
Diagnostics World | This week Illumina announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.
May 27, 2022
-
Diagnostics World News | An AI-based diagnostic histoculture platform preserves human tumor microenvironment; FUJIFILM partners with over 150 imaging centers across the United States; two multiplex respiratory virus tests enable rapid differentiation and detection; and more.
May 26, 2022
-
Diagnostics World News| Funding for pathology diagnostics, rapid DNA sequencing, AI-powered disease detection, and more.
May 25, 2022